Frontier Science & Technology Research Foundation, Inc.   Report issue

Foundation Phase 2 Phase 3
Founded: Madison WI United States (1975)

Organization Overview

First Clinical Trial
2014
NCT02032823
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Frontier Science & Technology Research Foundation, Inc.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 3)

Clostridium Infections (Phase 3)

Communicable Diseases (Phase 3)

Complex Regional Pain Syndromes (Phase 2)

Heart Failure (Phase 2)

Infections (Phase 3)

Neuralgia (Phase 2)

Reflex Sympathetic Dystrophy (Phase 2)

Vascular Diseases (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 5